Search
for
Sort by
Research 151–180 of 461
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Oral Manifestations of Hematologic and Nutritional Diseases
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- TOXIC EPIDERMAL NECROLYSIS
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- SLE and Serum Complement: Causative, Concomitant or Coincidental?
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- The Clinical Presentation of Systemic Lupus Erythematosus
- Telogen Effluvium
- Recent advances in the treatment of psoriasis
- Psychodermatology
- Guidelines for the Use of Acitretin in Psoriasis
- Nutrition and the deleterious side effects of nutritional supplements
- AMINOPTERIN IN TREATMENT OF LEUKEMIA IN CHILDREN
- INTERFERONS IN DERMATOLOGY
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Thrombocytosis Associated with Low-Molecular-Weight Heparin
- Adult Group B Streptococcal Disease
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- CUTANEOUS T-CELL LYMPHOMA
- Immunomodulators in the treatment of cutaneous lymphoma
- NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series
- Clinical Development of Topoisomerase-Interactive Drugs
- Clinical and immunological characteristics of 56 patients with systemic lupus erythematosus in Uganda
- Hair loss